Skip to content
MedCompare

Gefitinib

Also known as Iressa (us), Geftinat (india)

Cancer & Oncology
Save $3,773/mo
66× cheaper

Gefitinib is used to treat non-small cell lung cancer that has spread to other parts of the body in people with certain types of tumors. Gefitinib is in a class of medications called kinase inhibitors.

United States
$3,830
per month
India
$58
per month
You save
$3,773
98% cheaper in India
868 US scripts/yr$3.3M potential annual savings$3.3M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC22H24ClFN4O3

SMILES: COC1=C(C=C2C(=C1)N=CN=C2NC3=CC(=C(C=C3)F)Cl)OCCCN4CCOCC4

Compare the price
US price$3,830per month
India price$58per month
You save$3,77398% less

Based on 30 units per month. US $127.68 vs India $1.93 per unit.

Total over 1 periodSave $3,773$3,830 → $58
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$22,636
Estimated travel cost
− $2,300
Net savings after travel
$20,336

Even after travel, you could come out ahead by about $20,336.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Gefitinib is filled about 868 times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$3.3M
If sourced from India
$50.2K
Potential annual savings
$3.3M
−98%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.